Clinical studies to implement Rheopheresis for age-related macular degeneration guided by evidence-based-medicine (Q35183853)

7 August 2017

1 reference

title

Clinical studies to implement Rheopheresis for age-related macular degeneration guided by evidence-based-medicine (English)

1 reference

7 August 2017

1 reference

Reinhard Klingel

1 reference

7 August 2017

Cordula Fassbender

series ordinal

1 reference

7 August 2017

Thurid Fassbender

series ordinal

1 reference

7 August 2017

Britta Göhlen

series ordinal

1 reference

7 August 2017

publication date

1 August 2003

1 reference

Transfusion and Apheresis Science

7 August 2017

published in

1 reference

7 August 2017

1 reference

7 August 2017

1 reference

7 August 2017

page(s)

71-84

1 reference

Ocular perfusion and age-related macular degeneration.

7 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2803%2900101-0

7 January 2021

Age-related macular degeneration

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2803%2900101-0

7 January 2021

Long-term drusen study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2803%2900101-0

7 January 2021

A model of the incidence and consequences of choroidal neovascularization secondary to age-related macular degeneration. Comparative effects of current treatment and potential prophylaxis on visual outcomes in high-risk patients

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2803%2900101-0

7 January 2021

Ten-year incidence and progression of age-related maculopathy: The Beaver Dam eye study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2803%2900101-0

7 January 2021

An integrated hypothesis that considers drusen as biomarkers of immune-mediated processes at the RPE-Bruch's membrane interface in aging and age-related macular degeneration

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2803%2900101-0

7 January 2021

Changes of astrocytes in retinal ageing and age-related macular degeneration

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2803%2900101-0

7 January 2021

Plasma fibrinogen levels, other cardiovascular risk factors, and age-related maculopathy: the Blue Mountains Eye Study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2803%2900101-0

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2803%2900101-0

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2803%2900101-0

7 January 2021

A Hemodynamic Model of the Pathogenesis of Age-related Macular Degeneration

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2803%2900101-0

7 January 2021

Effect of Aging on Foveolar Choroidal Circulation

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2803%2900101-0

7 January 2021

Pulsatile ocular blood flow in asymmetric exudative age related macular degeneration

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2803%2900101-0

7 January 2021

Transforming growth factor-beta regulates human retinal pigment epithelial cell phagocytosis by influencing a protein kinase C-dependent pathway.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2803%2900101-0

7 January 2021

Shear stress as an inhibitor of vascular smooth muscle cell proliferation. Role of transforming growth factor-beta 1 and tissue-type plasminogen activator

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2803%2900101-0

7 January 2021

Pigment-epithelium-derived factor--a key coordinator of retinal neuronal and vascular functions

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2803%2900101-0

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2803%2900101-0

7 January 2021

Limited plasmin proteolysis of vitronectin. Characterization of the adhesion protein as morpho-regulatory and angiostatin-binding factor

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2803%2900101-0

7 January 2021

Subcutaneous injection of a cyclic peptide antagonist of vitronectin receptor-type integrins inhibits retinal neovascularization

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2803%2900101-0

7 January 2021

Complement activation and inflammatory processes in Drusen formation and age related macular degeneration

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2803%2900101-0

7 January 2021

A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2803%2900101-0

7 January 2021

Verteporfin therapy for subfoveal choroidal neovascularization in age-related macular degeneration: three-year results of an open-label extension of 2 randomized clinical trials--TAP Report no. 5.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2803%2900101-0

7 January 2021

Retinal vascular changes associated with transpupillary thermotherapy for choroidal melanomas

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2803%2900101-0

7 January 2021

Influence of laser photocoagulation on choroidal capillary cytoarchitecture

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2803%2900101-0

7 January 2021

Transient appearance of classic choroidal neovascularization after transpupillary thermotherapy for occult choroidal neovascularization

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2803%2900101-0

7 January 2021

Laser burn intensity and the risk for choroidal neovascularization in the CNVPT Fellow Eye Study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2803%2900101-0

7 January 2021

Rheopheresis: rheologic, functional, and structural aspects

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2803%2900101-0

7 January 2021

Improvement of macular function by membrane differential filtration in diabetic retinopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2803%2900101-0

7 January 2021

Rheophoresis. A systematic approach to therapy of age-related macular degeneration (AMD)?

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2803%2900101-0

7 January 2021

Drusen in age-related macular degeneration: pathogenesis, natural course, and laser photocoagulation-induced regression

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2803%2900101-0

7 January 2021

Extracorporeal membrane differential filtration--a new and safe method to optimize hemorheology in acute ischemic stroke.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2803%2900101-0

7 January 2021

Fibrinogen and LDL apheresis in treatment of sudden hearing loss: a randomised multicentre trial

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2803%2900101-0

7 January 2021

Novel mechanism for age-related macular degeneration: an equilibrium shift between the angiogenesis factors VEGF and PEDF.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2803%2900101-0

7 January 2021

10.1016/S1473-0502(03)00101-0

Identifiers

DOI

1 reference

7 August 2017

1 reference